Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia

J Clin Psychopharmacol. 2015 Feb;35(1):101-2. doi: 10.1097/JCP.0000000000000267.

Authors

Yutaka Mizuki¹, Manabu Takaki

Affiliation

¹ Department of Neuropsychiatry Okayama University Graduate School of Medicine Dentistry, and Pharmaceutical Sciences Okayama, Japan Department of Neuropsychiatry Okayama University Graduate School of Medicine Dentistry, and Pharmaceutical Sciences Okayama, Japan manabuta@cc.okayama-u.ac.jp.

PMID: 25502488
DOI: 10.1097/JCP.0000000000000267

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antipsychotic Agents / adverse effects*
Female
Humans
Long QT Syndrome / chemically induced*
Long QT Syndrome / diagnosis*
Piperazines / therapeutic use*
Piperidines / therapeutic use*
Risperidone / adverse effects*
Schizophrenia / diagnosis
Schizophrenia / drug therapy*

Substances

Antipsychotic Agents
Piperazines
Piperidines
blonanserin
Risperidone